Author:
Muszkat Mordechai,Shapira Michael Y.,Sviri Sigal,Linton David M.,Caraco Yoseph
Abstract
Thrombotic thrombocytopenic purpura (TTP) occurs in association with a wide variety of disorders including infections, connective tissue diseases, and solid organ tumors. It also may coincide with administration of drugs such as mitomycin, metronidazole, oral contraceptives, cyclosporine, and many others. We report the occurrence of TTP in a patient shortly after the initiation of ticlopidine.
Reference22 articles.
1. The pathophysiology and management of thrombotic thrombocytopenic purpura
2. TTP — Desperation, Empiricism, Progress
3. Ticlopidine
4. Prevention of aorta‐coronary bypass graft occlusion. Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double‐blind study;Limet R;J Thorac Cardiovasc Surg,1987
5. Antithrombotic therapy after intracoronary stenting;Spilner S;Pharmacotherapy,1997